BEIJING, Nov. 10, 2020 /PRNewswire/ — Insilico Medicine, a leader in deep generative reinforcement learning for target discovery,
small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica N.V. (Janssen), one
of the Janssen Pharmaceutical Companies of Johnson & Johnson. The collaboration